Eli Lilly & Co. v. Medtronic, Inc.

SCOTUSCase
Litigants=Eli Lilly & Co. v. Medtronic, Inc.
ArgueDate=February 26
ArgueYear=1990
DecideDate=June 18
DecideYear=1990
FullName=Eli Lilly & Co. v. Medtronic, Inc.
USVol=496
USPage=661
Docket=89-243
Citation=110 S. Ct. 2683; 110 L. Ed. 2d 605; 1990 U.S. LEXIS 3184; 58 U.S.L.W. 4838; 15 U.S.P.Q.2D (BNA) 1121
Prior=Certiorari to the Circuit Court of Appeal for the Federal Circuit.
Subsequent=Rehearing Denied, August 14, 1990, Reported at 1990 U.S. LEXIS 3730.
Holding=Section 271(e)(1) exempts from infringement the use of patented inventions reasonably related to the development and submission of information needed to obtain marketing approval of medical devices under the FDCA.
SCOTUS=1988-1990
Majority=Scalia
JoinMajority=Rehnquist, Brennan, Marshall, Blackmun, Stevens
Concurrence=
JoinConcurrence=
Concurrence2=
JoinConcurrence2=
Concurrence/Dissent=
JoinConcurrence/Dissent=
Dissent=Kennedy
JoinDissent=White
Dissent2=
JoinDissent2=
NotParticipating=O'Connor
LawsApplied=

"Eli Lilly & Co. v. Medtronic, Inc.", ussc|496|661|1990, is a United States Supreme Court case related to Patent infringement in the Medical device industry. It held that UnitedStatesCode|35|271(e)(1) of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.

ee also

* List of United States Supreme Court cases, volume 496

References

*ussc|496|661|1990 Full text opinion from Findlaw.com
* [http://neuro.law.cornell.edu/supct/html/89-243.ZO.html Opinion from Cornell-LII]